Search - tctmd.com

Displaying 81 - 100 of 104

Sort: Relevancy | Date

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

Study Suggests Noncardiac Surgery Can Be Safe as Early as 3 Months After PCI

Yael L. Maxwell

August 20, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Daily News

Clinical Variables Added to Syntax Score Increases Predictive Ability

L.A. McKeown

September 30, 2011

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

Advertisement

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Study Suggests Noncardiac Surgery Can Be Safe as Early as 3 Months After PCI

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Xience V Noninferior to Cypher for Primary PCI

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Experts Give Their Picks for Most Important Developments of 2011

PRISM Individualized Informed Consent Improves PCI Choice, Experience

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

Clinical Variables Added to Syntax Score Increases Predictive Ability

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content